Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Q1: "Other companies don't want P2O to succeed!"
A1: "PTOI only has a market cap of $3.5M. If any company was worried about PTOI, they would simply buy the company."
Q2: "Good point. Why won't any company buy PTOI?"
A2: "If P2O's technology worked as advertised, then some company would buy PTOI."
Q3: "No way! Other companies don't want P2O to succeed!"
A3: "Return to Q1 and collect 100 BAT-SHITTER points."
durrrrrrrrrrrrrrrr......
Q1: If P2O can do what Bordynuik claimed, then why did it shut down 7 years ago?
A1: Obviously because P2O can’t do what Bordynuik claimed it could do.
Q2: No way! P2O failed because of Naked Shorters.
A2: How could naked shorters stop Heddle and Brain from fixing and running the processors?
Q3: Great point! So if P2O can do what Bordynuik claimed, then why did it shut down 7 years ago?
A3: Please return to Q1 and collect 100 BAT-SHITTER points.
durrrrrrrrrrrrrr….
for *BAT-SHITTER'S'* sake .. PTOI (company) has been *held*
(without exception) @ 5c (or below) since October 2014
I would guess the next steps are...
based on 16 years and $120,000,000.00 worth of accumulated empirical evidence, all consistently and strongly supporting a single hypothesis...
another announcement about developing a "cure" for another viral disease, whenever the next new public scare arises, to ring in another round of saps.
NanoViricides Reports Initial Safety Results Regarding its Anti-Influenza and Bird Flu Drug
November, 2005
https://www.businesswire.com/news/home/20051107005498/en/NanoViricides-Reports-Initial-Safety-Results-Anti-Influenza-Bird
NanoViricides, Inc. to Tackle Asian Bird Flu
10/3/2005
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165482267
Novel Influenza and Bird Flu Therapeutics Moving Rapidly at NanoViricides, Inc. September, 2007
https://www.businesswire.com/news/home/20070904005487/en/Influenza-Bird-Flu-Therapeutics-Moving-Rapidly-NanoViricides
NanoViricides is on Course to Develop Bird Flu, Influenza, and Other Drugs January, 2008.
https://www.businesswire.com/news/home/20080122005644/en/NanoViricides-Develop-Bird-Flu-Influenza-Drugs
NanoViricides, Inc. Release: Anti-Dengue NanoViricides Achieve Significant Protection in Initial In Vivo Studies on Dengue Hemorrhagic Fever June, 2010
https://www.biospace.com/article/releases/nanoviricides-inc-release-anti-dengue-nanoviricides-achieve-significant-protection-in-initial-in-vivo-studies-on-dengue-hemorrhagic-fever-/
NanoViricides Reports That Oral Administration of FluCide®, its Anti-Influenza Drug Candidate Was Effective In Animal Model. Aug 13, 2012
https://www.fiercepharma.com/pharma/nanoviricides-reports-oral-administration-of-flucide®-its-anti-influenza-drug-candidate-was
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency November, 2013
http://www.nanoviricides.com/press%20releases/2013/NanoViricides%20Announces%20that%20DengueCide%E2%84%A2%20Has%20Received%20Orphan%20Drug%20Designation%20From%20the%20European%20Medicines%20Agency%20(EMA).html
NanoViricides President Dr. Diwan Presented FluCide Data at the 3rd Annual Influenza Conference June, 2014
https://www.businesswire.com/news/home/20140714005478/en/NanoViricides-President-Dr.-Diwan-Presented-FluCide-Data
NanoViricides Reports That It Has Designed and Commenced Synthesis of Novel Ebola Drug Candidates September, 2014
http://www.nanoviricides.com/press%20releases/2014/NanoViricides%20Reports%20That%20It%20Has%20Designed%20and%20Commenced%20Synthesis%20of%20Novel%20Ebola%20Drug%20Candidates.html
NanoViricides Reports that Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms in an Animal Model April 2015
https://www.biospace.com/article/releases/nanoviricides-inc-reports-that-its-topical-anti-herpes-treatment-dramatically-improves-clinical-symptoms-in-an-animal-model-/
NanoViricides Reports On Progress of Its Drug Candidates against Herpesviruse June 2016
https://www.prnewswire.com/news-releases/nanoviricides-reports-on-progress-of-its-drug-candidates-against-herpesviruses-300286916.html
NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of the Ocular Microbiology and Immunology Group (OMIG) of the American Academy of Ophthalmology October, 2017
http://www.nanoviricides.com/press%20releases/2017/NanoViricides%20to%20Present%20Results%20On%20Successful%20Treatment%20Of%20Herpes-Induced%20Acute%20Retinal%20Necrosis%20at%20the%20Annual%20Meeting.html
NanoViricides Provides Update, Says Company is Stable and is Moving Steadily towards Clinical Trials May,2018
https://www.biospace.com/article/releases/nanoviricides-provides-update-says-company-is-stable-and-is-moving-steadily-towards-clinical-trials/?s=86
https://www.prnewswire.com/news-releases/nanoviricides-reports-on-progress-of-its-drug-candidates-against-herpesviruses-300286916.html
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials Feb, 2019
https://www.accesswire.com/567044/NanoViricides-Files-Quarterly-Report-for-Period-Ending-September-30-2019--HerpeCide-Drug-Candidate-IND-Enabling-Studies-Update-Progressing-Towards-Clinical-Trials
NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses. May 12, 2020
https://ih.advfn.com/stock-market/AMEX/nanoviricides-NNVC/stock-news/82433957/nanoviricides-develops-highly-effective-broad-spec
NOW THAT REALLY IS BLOODY IRONY!!!!
OH MY GOD!!!!
WOW! WOW! WOW!
If you say so!
WHERE THE HELL ARE THE BLOODY DOX IN THE PROX FOR THE STOX ?!?!?
HMMMMMMMMMMM??!?!?!?!?
AND WHAT ABOUT THE BLOODY DECOYS?!?!?
WHERE THE HELL IS THE BAT-SHIT DECOY UPDATE???
Heddle might be getting some advice on how to increase his chances of selling the shell.
No point in broadcasting all the "warts" in that case.
How is removing all new after 2017 "updating" a website?
OPEN LETTER OF GRATITUDE TO RICK HEDDLE:
Thank you for coming on board as CEO, Chairman, shareholder, and debt holder. I know I speak for virtually every shareholder when I say: we thank you, for being a SHIPYARD MAN who doesn't pay attention to the sniveling and whining of man-children on the internet. Thank you for shutting down all operations since 2014 to save on utility bills.
Thank you to John Bordynuik as well, for your perseverance and triumphant effort in making millions of dollars from selling your Magik Katalyst story to gullible saps. You've risen like a phoenix from the ashes, and made a new life for yourself in the gummy bear industry, after having been sued for fraud by two different regulatory agencies in two different countries.
Finally, thanks to all the employees and to the Board of Directors, for their unwavering dedication towards maintaining an impeccably consistent level of machine operation over so many years.
Sincerely,
Arvitar
SEC CHARGES COMPANY AND ITS OFFICERS WITH ACCOUNTING FRAUD
From your link.
Nice!
Q1: "Why won't Heddle hire people to run the company?"
A1: "The company has no money to hire people"
Q2: "Then why won't Heddle pay salaries from his own pocket?"
A2: "If he was inclined to put in that much money, he would have already paid to fix the processors 7YRs ago."
Q3: "NO WAY!!!! P2O failed because of NAKED SHORTERS !!!"
A3: "How could NAKED SHORTERS have prevented Heddle from fixing the processors? "
Q4: "Good point! Why won't Heddle hire people to run the company?"
A4: "Please return to Q1 and collect 100 BAT-SHITTER points"
So, in your opinion, taxpayers should subsidize a money-losing scam so bag holders can recover the money that Bordynuik and Heddle swindled from them?
How likely is that?
Seriously, what on earth would anyone who wasn't lobotomized expect after 16 years of lies about developing "cures" that have all led to nothing?
Good grief....
-------------------
NanoViricides Reports Initial Safety Results Regarding its Anti-Influenza and Bird Flu Drug
November, 2005
https://www.businesswire.com/news/home/20051107005498/en/NanoViricides-Reports-Initial-Safety-Results-Anti-Influenza-Bird
NanoViricides, Inc. to Tackle Asian Bird Flu
10/3/2005
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165482267
Novel Influenza and Bird Flu Therapeutics Moving Rapidly at NanoViricides, Inc. September, 2007
https://www.businesswire.com/news/home/20070904005487/en/Influenza-Bird-Flu-Therapeutics-Moving-Rapidly-NanoViricides
NanoViricides is on Course to Develop Bird Flu, Influenza, and Other Drugs January, 2008.
https://www.businesswire.com/news/home/20080122005644/en/NanoViricides-Develop-Bird-Flu-Influenza-Drugs
NanoViricides, Inc. Release: Anti-Dengue NanoViricides Achieve Significant Protection in Initial In Vivo Studies on Dengue Hemorrhagic Fever June, 2010
https://www.biospace.com/article/releases/nanoviricides-inc-release-anti-dengue-nanoviricides-achieve-significant-protection-in-initial-in-vivo-studies-on-dengue-hemorrhagic-fever-/
NanoViricides Reports That Oral Administration of FluCide®, its Anti-Influenza Drug Candidate Was Effective In Animal Model. Aug 13, 2012
https://www.fiercepharma.com/pharma/nanoviricides-reports-oral-administration-of-flucide®-its-anti-influenza-drug-candidate-was
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency November, 2013
http://www.nanoviricides.com/press%20releases/2013/NanoViricides%20Announces%20that%20DengueCide%E2%84%A2%20Has%20Received%20Orphan%20Drug%20Designation%20From%20the%20European%20Medicines%20Agency%20(EMA).html
NanoViricides President Dr. Diwan Presented FluCide Data at the 3rd Annual Influenza Conference June, 2014
https://www.businesswire.com/news/home/20140714005478/en/NanoViricides-President-Dr.-Diwan-Presented-FluCide-Data
NanoViricides Reports That It Has Designed and Commenced Synthesis of Novel Ebola Drug Candidates September, 2014
http://www.nanoviricides.com/press%20releases/2014/NanoViricides%20Reports%20That%20It%20Has%20Designed%20and%20Commenced%20Synthesis%20of%20Novel%20Ebola%20Drug%20Candidates.html
NanoViricides Reports that Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms in an Animal Model April 2015
https://www.biospace.com/article/releases/nanoviricides-inc-reports-that-its-topical-anti-herpes-treatment-dramatically-improves-clinical-symptoms-in-an-animal-model-/
NanoViricides Reports On Progress of Its Drug Candidates against Herpesviruse June 2016
https://www.prnewswire.com/news-releases/nanoviricides-reports-on-progress-of-its-drug-candidates-against-herpesviruses-300286916.html
NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of the Ocular Microbiology and Immunology Group (OMIG) of the American Academy of Ophthalmology October, 2017
http://www.nanoviricides.com/press%20releases/2017/NanoViricides%20to%20Present%20Results%20On%20Successful%20Treatment%20Of%20Herpes-Induced%20Acute%20Retinal%20Necrosis%20at%20the%20Annual%20Meeting.html
NanoViricides Provides Update, Says Company is Stable and is Moving Steadily towards Clinical Trials May,2018
https://www.biospace.com/article/releases/nanoviricides-provides-update-says-company-is-stable-and-is-moving-steadily-towards-clinical-trials/?s=86
https://www.prnewswire.com/news-releases/nanoviricides-reports-on-progress-of-its-drug-candidates-against-herpesviruses-300286916.html
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials Feb, 2019
https://www.accesswire.com/567044/NanoViricides-Files-Quarterly-Report-for-Period-Ending-September-30-2019--HerpeCide-Drug-Candidate-IND-Enabling-Studies-Update-Progressing-Towards-Clinical-Trials
NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses. May 12, 2020
https://ih.advfn.com/stock-market/AMEX/nanoviricides-NNVC/stock-news/82433957/nanoviricides-develops-highly-effective-broad-spec
Q1: "But why won't Heddle or Brain spend a few bucks to fix the processors?"
A1: "Obviously they would if they could run them at a profit"
Q2: "NO WAY!!!! P2O failed because of NAKED SHORTERS !!!"
A2: "How could NAKED SHORTERS have prevented Heddle and Brain from fixing the processors? "
Q3: "Good point! Why won't Heddle and Brain spend a few bucks to fix the processors"?
A3: "Please return to Q1 and collect 100 BAT-SHITTER points"
Q1: "What is Heddle's next step?"
A1: To sell the non-operational shell to someone who wants to do a reverse merger."
Q2: "But then why would Heddle the keep the company alive?"
A2: "So he can sell the non-operational shell to someone who wants to do a reverse merge."
Q3: "So what's Heddle's next step?"
A3: "Return to Q1 and collect 100 BAT-SHITTER points."
Dude, it’s too late. Statute of limitations and all.
Q1: "But why won't Heddle or Brain spend a few bucks to fix the processors?"
A1: "Obviously they would if they could run them at a profit"
Q2: "NO WAY!!!! P2O failed because of NAKED SHORTERS !!!"
A2: "How could NAKED SHORTERS have prevented Heddle and Brain from fixing the processors? "
Q3: "Good point! Why won't Heddle and Brain spend a few bucks to fix the processors"?
A3: "Please return to Q1 and collect 100 BAT-SHITTER points"
Q1: "What is Heddle's next step?"
A1: To sell the non-operational shell to someone who wants to do a reverse merger."
Q2: "But then why would Heddle file the paperwork to keep the company alive?"
A2: "So he could sell the non-operational shell to someone who wants to do a reverse merge."
Q3: "So what's Heddle's next step?"
A3: "Return to Q1 and collect 100 BAT-SHITTER points."
Well, let's clear up a couple of misconceptions about Heddle.
First, what's apparent from the news stories that are publicly available, is that Heddle sought investors to put money into his business, and they came in on terms that required him to step aside from running his company. He took a demotion to COO, and some kid, Shaun Padulo, has been running Heddle Shipyards for the past 3 years. So Heddle might not be as universally regarded as being an awesome businessman as believed by the common folk around Hamilton.
Second, it's not conceivable that Heddle wasn't in on the P2O scam from its beginning. Nobody really believes that Heddle intended to retrofit his ships with nonexistent processors that relied on a Magic Catalyst, sail the Atlantic, and recover plastic from the ocean floor at an average depth of 3,500ft, do they?
https://www.globenewswire.com/news-release/2009/12/22/411271/11616/en/JBI-Inc-Executes-JV-LOI-With-Rick-Heddle-Signs-LOI-for-45-Florida-P2O-Sites-and-Will-Apply-for-ASE-Listing.html
https://www.plastic2oil.com/site/news-releases-master/2010/02/12/jbi-incs-p20-marine-inc--rick-heddles-rwh-marine-consulting-inc-sign-principal-definitive-contract-for-a-p2o-ship-development-agreement-sda
Third, Heddle withheld material information from the investing public after the processors blew up, allowing everyone to continue thinking that P20 was operational and producing oil for six months after it had shut down all operations.
Nor does anyone really think Heddle believed that Bordynuik found a lost Magic Catalyst on a magnetic tape from 1970 that would revolutionize the pyrolysis industry, do they? A fairy tale told by a guy who was nailed for fraud by two different regulatory agencies in two different countries?
In other words, it's not inconsistent for someone to be a respected and competent business man, and to also be actively involved themselves in perpetrating a scam targeting the absolute dumbest in society.
I mean, the successful and competent billionaire Tom Barack was just indicted for being an agent working at the direction of a foreign power. It's not like he needed the money.
Why doesn't anyone ever whimper and snivel to Heddle on the weekends?
Perhaps that's the only time he reads the SMBs to see if any bagholders are sending him important messages.
The *only* thing that matters to actual PTOI investors is BAT-SHITTERY.
Since this is a FACT,
WHERE THE HELL IS THE BLOODY DECOY UPDATE ?!?!?!?
HMMMMMMMMMMMMMMM????????????????
Durrrrrrrrr…. Gurgle…gurgle…
Durrrrrrrrrrrrrrrrr…..
POST OF THE YEAR HERE !!!!
MODS - PLEASE STICKY THIS!!!
OH MY GOD!!!
WOW! WOW! WOW!
Q1: "But why won't Heddle spend a few buck to fix the processors?"
A1: "Obviously he would if he could run them at a profit"
Q2: "NO WAY!!!! P2O failed because of NAKED SHORTERS !!!"
A2: "How could NAKED SHORTERS have prevented Heddle from fixing the processors? "
Q3: "Good point! Why won't Heddle spend a few buck to fix the processors"?
A3: "Please return to Q1 and collect 100 BAT-SHITTER points"
NO THEY DON’T !!!
HEDDLE NEVER READS SHIT-STOCK MESSAGE BOARDS !!!
GOOD GRIEF !!!
Of for god's sake.
Heddle doesn't read these boards.
But if he did, he would inform you that he's trying to sell this inactive shell for a few hundred thousand dollars.
NEWS — NanoViricides, Inc. to Tackle Asian Bird Flu
10/3/2005 1:19:01 PM
WEST HAVEN, Conn., Oct 03, 2005 (BUSINESS WIRE) -- NanoViricides, Inc. (Pink Sheets:NNVC - News), today announced that it is moving rapidly forward with its strategy for combating Avian Flu. "If our FluCide-I influenza drug meets the initial expectations, we can modify it very quickly to develop a nanoviricide against the avian flu," explained Dr. Diwan, President, "We simply reset the nanoviricide's target to H5N1, the bird flu virus!" The Company has scheduled high-level meetings in December with Vietnam's senior government officials and scientists regarding avian flu. "This invitation by the Vietnamese government gives us an enormous advantage over most other companies, including large cap biotech firms," said the CEO, Eugene Seymour, MD, MPH. The Company anticipates having preclinical data available to share on its Flucide-I influenza (nanoviricide) drug and considers this a unique opportunity to access the wealth of information available in Vietnam on bird flu.
Two days ago, the US Senate passed a $4 Billion bill to purchase TamiFlu(TM) (Roche) and also to pursue additional strategies for prevention as well as treatment. Tamiflu(TM) has limited effectiveness but remains the only means of treatment against avian flu at present. The Senate funding move came the same day the United Nations' new avian flu coordinator Dr. David Nabarro warned that a flu pandemic could kill millions of people worldwide.
"Developing targeted therapies for both usual Influenza and Avian Flu will enable the company to tap into the billions of dollars now available from both the Department of Defense and the Department of Homeland Security," Dr. Seymour continued, "We are now giving the highest priority to Influenza and Avian Flu."
http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile.
SOURCE: NanoViricides, Inc.
NanoViricides, Inc.
Leo Ehrlich, 917-853-6440
leo*nanoviricides.com
NEWS — NanoViricides Reports That Oral Administration of FluCide®, its Anti-Influenza Drug Candidate Was Effective In Animal Model.
Aug 13, 2012 9:08am
https://www.fiercepharma.com/pharma/nanoviricides-reports-oral-administration-of-flucide®-its-anti-influenza-drug-candidate-was
That would explain it.
I mean, the only other explanation is that Bordynuik was defrauding the investing public, but that's not possible.
"The beauty of the agreement with RockTenn, in combination with the fuel supply agreements with Indigo Energy and XTR Energy, is that we will be free to focus solely on the manufacturing of additional P2O processors as we move into 2012," says Bordynuik. "It's a huge step forward in achieving our vision of becoming a vertically integrated plastic recycling, fuel processing and fuel distribution company."
https://www.globenewswire.com/fr/news-release/2011/12/30/464476/11616/en/JBI-Inc-CEO-Bordynuik-Recaps-2011-Progress-and-Key-Milestones.html
Didn't PTOI already fail when Heddle shut down all operations 7 years ago?
How much more can a company be made to fail after running out of money and closing its doors?